Conference Reports for NATAP
17th International Workshop
on Clinical Pharmacology of
HIV and Hepatitis Therapy
June 8-10, 2016, Washington DC
Back
 
Tweet
Cabotegravir Long-Acting (LA) Injectable Nanosuspension
Bill Spreen, for ViiV Healthcare & GSK Development Team
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy